The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks89DG.L Regulatory News (89DG)

  • There is currently no data for 89DG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business impact of coronavirus on NATS – update

1 Apr 2020 15:37

RNS Number : 4604I
NATS (En Route) PLC
01 April 2020
 

Business impact of coronavirus on NATS - update

 

We continue to work with customers and authorities to understand the impact of COVID-19 on our business. In the meantime, we have elected to fully draw down on our £400m committed bank facilities, such that this liquidity is now held on our balance sheet. 

 

ENDS

 

About NATS

 

NATS is a leading air traffic management and solutions company, established in the UK in 1962 and now operating in countries around the world.

 

NATS handled 2.6 million flights in 2019, covering the UK and eastern North Atlantic from its centres at Swanwick, Hampshire and Prestwick, Ayrshire. NATS also provides air traffic services at 13 UK airports; at Gibraltar Airport and, in a joint venture with Ferrovial, at a number of airport towers in Spain.

 

Building on its reputation for operational excellence and innovation, NATS offers aerodrome, data, engineering, capacity, efficiency and environmental performance solutions to customers worldwide, including airports, airlines air traffic service providers and governments.

 

For more information visit the NATS website at www.nats.aero 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFVSSVILIII
Date   Source Headline
27th Oct 202210:06 amRNSCAA publish initial proposals for NR23 (2023-2027)
1st Jul 20227:00 amRNSAnnual Financial Report
31st Mar 20223:56 pmRNSExtension to bank facilities
1st Mar 20222:45 pmRNSRevision to proposed business plan
7th Feb 202212:33 pmRNSNATS proposed business plan for upcoming NR23
12th Jul 20217:00 amRNSAnnual Financial Report
8th Jun 20213:46 pmRNSNotice of redemption of bonds
4th Jun 20215:39 pmRNSRedemption of amortising bonds due 2026
28th May 20217:00 amRNSDividend Declaration
29th Apr 20217:00 amRNSNATS pricing of new bonds
26th Apr 20218:30 amRNSNew bonds issuance escrow & redemption
23rd Apr 20217:00 amRNSRDP Decision & Trading Update
30th Mar 20217:00 amRNSRefinancing Regulated Decision Proposal
2nd Dec 20209:52 amRNSNATS notes CAA consultation
27th Nov 20207:00 amRNSDividend Declaration
23rd Oct 20207:00 amRNSAnnual Financial Report
7th Aug 20207:03 amRNSStatement re bank facility
23rd Jul 20207:14 amRNSStatement re. CMA Final Determination
22nd May 20207:00 amRNSNo interim dividend to shareholders in May 2020
5th May 20205:45 pmRNSStatement re financial covenant waiver
1st Apr 20203:37 pmRNSBusiness impact of coronavirus on NATS – update
24th Mar 20207:11 amRNSCMA initial findings regarding NATS settlement
17th Mar 20201:48 pmRNSStatement: Business impact of coronavirus on NATS
29th Nov 20197:00 amRNSDividend Declaration
20th Nov 20197:00 amRNSNATS regulatory settlement referred to CMA
12th Sep 20197:00 amRNSNATS (En Route) plc - transfer of securities
28th Jun 20197:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.